PHA Weighs in on Proposed Regulations
PHA weighs in on proposed regulations about prior authorization, step therapy, medical research and Medicaid work requirements.
News
In the News
Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
Recent news
Dislaying 19 — 24 of 405
-
-
AnMed Uses Social Media To Put Patients at Ease
AnMed Medical Center found a creative way to help patients feel less scared and anxious about procedures and tests outside the PH clinic.
News
-
Awkwafina To Compete for PHA in ‘Who Wants To Be a Millionaire’Awkwafina competes on "Who Wants To Be a Millionaire" to support the Pulmonary Hypertension Association in honor of her mother.
News
-
Updated ‘Navigating PH’ Emphasizes Comprehensive Patient CareDownload PHA’s updated guide for patients and families, offering trusted support and information at every stage of the PH journey.
News
-
Survey Highlights Invisible Burden of Pediatric PH CaregiversNew survey findings reveal the invisible burdens faced by caregivers of children with PH.
News | Pediatric PH
-
SOAR Act Gains Traction from PHA Advocacy EffortsPHA advocacy efforts helped the Supplemental Oxygen Access Reform Act gain 12 new cosponsors.
News
PH in the News
-
Liquidia and United Therapeutics Announce Global Settlement Resolving All Pending Litigation
The settlement follows a September 2026 federal court ruling in favor of United Therapeutics regarding two patent infringement claims related to the use of inhaled treprostinil for PH-ILD. No safety concerns were raised.
-
FDA OKs sotatercept label update
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
-
Pulmovant opens Phase 3 mosliciguat study
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.